These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 18708243

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Intense neoadjuvant chemotherapy with cisplatin and epirubicin for advanced or bulky cervical and vaginal adenocarcinoma.
    Zanetta G, Lissoni A, Gabriele A, Landoni F, Colombo A, Perego P, Mangioni C.
    Gynecol Oncol; 1997 Mar; 64(3):431-5. PubMed ID: 9062145
    [Abstract] [Full Text] [Related]

  • 4. Neoadjuvant chemotherapy with paclitaxel plus platinum followed by radical surgery in early cervical cancer during pregnancy: three case reports.
    Chun KC, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH.
    Jpn J Clin Oncol; 2010 Jul; 40(7):694-8. PubMed ID: 20427545
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Neoadjuvant chemotherapy and conservative surgery for stage IB1 cervical cancer.
    Maneo A, Chiari S, Bonazzi C, Mangioni C.
    Gynecol Oncol; 2008 Dec; 111(3):438-43. PubMed ID: 18835493
    [Abstract] [Full Text] [Related]

  • 7. Neoadjuvant chemotherapy and vaginal radical trachelectomy for fertility-sparing treatment in women affected by cervical cancer (FIGO stage IB-IIA1).
    Marchiole P, Tigaud JD, Costantini S, Mammoliti S, Buenerd A, Moran E, Mathevet P.
    Gynecol Oncol; 2011 Sep; 122(3):484-90. PubMed ID: 21636113
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Neoadjuvant cisplatin and etoposide followed by radical hysterectomy for stage 1B-2B cervical cancer.
    Bae JH, Lee SJ, Lee A, Park YG, Bae SN, Park JS, Namkoong SE.
    Gynecol Oncol; 2008 Dec; 111(3):444-8. PubMed ID: 18829085
    [Abstract] [Full Text] [Related]

  • 10. Neoadjuvant concurrent paclitaxel and radiation in stage II/III breast cancer.
    Chakravarthy AB, Kelley MC, McLaren B, Truica CI, Billheimer D, Mayer IA, Grau AM, Johnson DH, Simpson JF, Beauchamp RD, Jones C, Pietenpol JA.
    Clin Cancer Res; 2006 Mar 01; 12(5):1570-6. PubMed ID: 16533783
    [Abstract] [Full Text] [Related]

  • 11. Phase III trial of observation versus six courses of paclitaxel in patients with advanced epithelial ovarian cancer in complete response after six courses of paclitaxel/platinum-based chemotherapy: final results of the After-6 protocol 1.
    Pecorelli S, Favalli G, Gadducci A, Katsaros D, Panici PB, Carpi A, Scambia G, Ballardini M, Nanni O, Conte P, After 6 Italian Cooperative Group.
    J Clin Oncol; 2009 Oct 01; 27(28):4642-8. PubMed ID: 19704064
    [Abstract] [Full Text] [Related]

  • 12. Neoadjuvant chemotherapy-specific and overall treatment outcomes in patients with cutaneous angiosarcoma of the face with periorbital involvement.
    DeMartelaere SL, Roberts D, Burgess MA, Morrison WH, Pisters PW, Sturgis EM, Ho V, Esmaeli B.
    Head Neck; 2008 May 01; 30(5):639-46. PubMed ID: 18213722
    [Abstract] [Full Text] [Related]

  • 13. Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy.
    Kaufman DS, Winter KA, Shipley WU, Heney NM, Wallace HJ, Toonkel LM, Zietman AL, Tanguay S, Sandler HM.
    Urology; 2009 Apr 01; 73(4):833-7. PubMed ID: 19100600
    [Abstract] [Full Text] [Related]

  • 14. Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patients.
    Di Lorenzo G, Cartenì G, Autorino R, Gonnella A, Perdonà S, Ferro M, Longo N, Rescigno P, Doria F, Faiella A, Altieri V, Palmieri G, Imbimbo C, Mirone V, De Placido S.
    Anticancer Drugs; 2009 Apr 01; 20(4):277-80. PubMed ID: 19262371
    [Abstract] [Full Text] [Related]

  • 15. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
    Finnegan V, Parsons JT, Greene BD, Sharma V.
    Head Neck; 2009 Feb 01; 31(2):167-74. PubMed ID: 18853443
    [Abstract] [Full Text] [Related]

  • 16. Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy.
    Demaria S, Volm MD, Shapiro RL, Yee HT, Oratz R, Formenti SC, Muggia F, Symmans WF.
    Clin Cancer Res; 2001 Oct 01; 7(10):3025-30. PubMed ID: 11595690
    [Abstract] [Full Text] [Related]

  • 17. Neoadjuvant chemotherapy: an alternative option of treatment for locally advanced cervical cancer.
    Loizzi V, Cormio G, Vicino M, Selvaggi L.
    Gynecol Obstet Invest; 2008 Oct 01; 65(2):96-103. PubMed ID: 17878736
    [Abstract] [Full Text] [Related]

  • 18. Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma.
    Safra T, Menczer J, Bernstein RM, Shpigel S, Matcejevsky D, Inbar MJ, Golan A, Grisaru D, Levy T.
    Gynecol Oncol; 2009 Aug 01; 114(2):215-8. PubMed ID: 19446318
    [Abstract] [Full Text] [Related]

  • 19. A less radical treatment option to the fertility-sparing radical trachelectomy in patients with stage I cervical cancer.
    Rob L, Pluta M, Strnad P, Hrehorcak M, Chmel R, Skapa P, Robova H.
    Gynecol Oncol; 2008 Nov 01; 111(2 Suppl):S116-20. PubMed ID: 18725167
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
    Keam B, Im SA, Kim HJ, Oh DY, Kim JH, Lee SH, Chie EK, Han W, Kim DW, Cho N, Moon WK, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    Breast Cancer Res Treat; 2009 Jul 01; 116(1):153-60. PubMed ID: 18787948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.